ecrin-mdr-crcClinical2019Colorectal cancerColorectal CancerObservationalhttps://newmdr.ecrin.org/Study/2688354China11ECRIN MDRRecruitingfalseA prospective, non-interventional, multicenter clinical study to explore the efficacy and safety of camrelizumab in combination with regorafenib in patients with advanced colorectal cancerInterventions: Case series:Drug intervention Primary outcome(s): PFS Study Design: Single arm2019-11-152688354ChiCTR1900027398